Cargando…
Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation
Even with recent substantive improvements in health care in pediatric populations, considerable need remains for additional safe and effective interventions for the prevention and treatment of diseases in children. The approval of prescription drugs and biological products for use in pediatric setti...
Autores principales: | Fleming, Thomas R., Garnett, Christine E., Conklin, Laurie S., Corriol-Rohou, Solange, Hariharan, Sudharshan, Hsu, Daphne, Mueller-Velten, Guenther, Mulugeta, Yeruk, Portman, Ronald, Rothmann, Mark D., Stockbridge, Norman L., Wandel, Simon, Zhang, Jialu, Yao, Lynne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755084/ https://www.ncbi.nlm.nih.gov/pubmed/36057747 http://dx.doi.org/10.1007/s43441-022-00445-6 |
Ejemplares similares
-
Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop
por: Barrett, Jeffrey S., et al.
Publicado: (2020) -
How is the Pharmaceutical Industry Structured to Optimize Pediatric Drug Development? Existing Pediatric Structure Models and Proposed Recommendations for Structural Enhancement
por: Severin, Thomas, et al.
Publicado: (2020) -
Optimizing Pediatric Medicine Developments in the European Union Through Pragmatic Approaches
por: Rei Bolislis, Winona, et al.
Publicado: (2021) -
Extrapolation of praziquantel pharmacokinetics to a pediatric population: a cautionary tale
por: Bonate, Peter L., et al.
Publicado: (2018) -
Adequacy of safety data for regulatory approval of pediatric indication through extrapolation algorithm
por: Park, Min Soo
Publicado: (2021)